Personal profile
Fingerprint
Dive into the research topics where Adi Lahat Zok is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 5 Article
-
Risankizumab for Ulcerative Colitis Two Randomized Clinical Trials
Louis, E., Schreiber, S., Panaccione, R., Bossuyt, P., Biedermann, L., Colombel, J. F., Parkes, G., Peyrin-Biroulet, L., D'Haens, G., Hisamatsu, T., Siegmund, B., Wu, K., Boland, B. S., Melmed, G. Y., Armuzzi, A., Levine, P., Kalabic, J., Chen, S., Cheng, L. & Shu, L. & 315 others, , 17 Sep 2024, In: JAMA. 332, 11, p. 881-897 17 p.Research output: Contribution to journal › Article › peer-review
Open Access110 Scopus citations -
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience
Lichtenstein, L., Koslowsky, B., Ya’acov, A. B., Avni-Biron, I., Ovadia, B., Ben-Bassat, O., Naftali, T., Kopylov, U., Haberman, Y., Eran, H. B., Eliakim, R., Lahat-Zok, A., Hirsch, A., Zittan, E., Maharshak, N., Waterman, M., Israeli, E., Goren, I., Ollech, J. E. & Yanai, H. & 27 others, , 1 Mar 2022, In: Vaccines. 10, 3, 376.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
GARDENIA Study Group, 1 Feb 2022, In: The Lancet Gastroenterology and Hepatology. 7, 2, p. 118-127 10 p.Research output: Contribution to journal › Article › peer-review
Open Access88 Scopus citations -
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Panés, J., García-Olmo, D., Van Assche, G., Colombel, J. F., Reinisch, W., Baumgart, D. C., Dignass, A., Nachury, M., Ferrante, M., Kazemi-Shirazi, L., Grimaud, J. C., de la Portilla, F., Goldin, E., Richard, M. P., Diez, M. C., Tagarro, I., Leselbaum, A., Danese, S., Stift, A. & Tschmelitsch, J. & 52 others, , 1 Apr 2018, In: Gastroenterology. 154, 5, p. 1334-1342.e4Research output: Contribution to journal › Article › peer-review
422 Scopus citations -
Ustekinumab as induction and maintenance therapy for Crohn's disease
UNITI-IM-UNITI Study Group, 17 Nov 2016, In: New England Journal of Medicine. 375, 20, p. 1946-1960 15 p.Research output: Contribution to journal › Article › peer-review
Open Access1655 Scopus citations